Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Non-Current Assets (2016 - 2020)

China Pharma Holdings' Other Non-Current Assets history spans 8 years, with the latest figure at $222996.0 for Q2 2020.

  • For Q2 2020, Other Non-Current Assets fell 55.69% year-over-year to $222996.0; the TTM value through Jun 2020 reached $222996.0, down 55.69%, while the annual FY2019 figure was $109908.0, 91.37% down from the prior year.
  • Other Non-Current Assets reached $222996.0 in Q2 2020 per CPHI's latest filing, down from $331038.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.6 million in Q2 2017 to a low of $109908.0 in Q4 2019.
  • Average Other Non-Current Assets over 5 years is $1.1 million, with a median of $1.2 million recorded in 2018.
  • Peak YoY movement for Other Non-Current Assets: surged 104.92% in 2017, then plummeted 91.37% in 2019.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.1 million in 2016, then plummeted by 34.81% to $709796.0 in 2017, then soared by 79.48% to $1.3 million in 2018, then tumbled by 91.37% to $109908.0 in 2019, then surged by 102.89% to $222996.0 in 2020.
  • Per Business Quant, the three most recent readings for CPHI's Other Non-Current Assets are $222996.0 (Q2 2020), $331038.0 (Q1 2020), and $109908.0 (Q4 2019).